Clinical Trials

Bone Metastasis:

CZOL446E2352:  A Phase III 3-arm study of continued efficacy and safety of Zometa for patients with breast cancer and bone metastases. [VCHOS]

For more information on VCHOS trials, please call Ruth Ann Begun, OCN at (805) 485-8709 ext 136 or email at rbegun@venturaoncology.com       

For more information on  UCLA network trials, please call  Pamela Riach, RN at (805) 485-8709 ext 129 or email at priach@mednet.ucla.edu.